-+ 0.00%
-+ 0.00%
-+ 0.00%

Harmony Biosciences Hldgs Affirms Prelim FY2026 Sales Guidance of $1.000B-$1.040B vs $1.014B Est

Benzinga·07/16/2026 12:38:04
語音播報

Harmony Biosciences Hldgs (NASDAQ:HRMY) affirms prelim FY2026 sales outlook from $1.000 billion-$1.040 billion to $1.000 billion-$1.040 billion vs $1.014 billion estimate.